Cancer is the second leading cause of death worldwide, leading to 9.6 million deaths per year. It is staggering that the global cancer burden is expected to double by 2040,. If we don’t act now this burden will be an even more serious problem for the world. The death rate of cancer in over 50 years hasn't changed. We've made small wins in cancer diseases like chronic myelogenous leukemia - an aggressive blood cancer— chemotherapy puts an estimated 60% of patients under 60 into remission following their first phase of treatment, but in general, we haven't made an impact at all in the war on other cancer.

There are like 50-plus years of good cancer research that discovered major technologies that taught us about cancer. But it is striking when we see the data in terms of the world's cancer cases Asia has around 48.3%, Oceania has around 1.3% of the worlds cancer cases, Africa has around 5.7% of the worlds cancer cases, South America and The Caribean has around 7.6% of the worlds cancer cases, Northern America has around 13.3% of the worlds cancer cases and Europe has around 22.8% of the worlds cancer cases. But all that said, we have a lot of heavy lifting to still do ahead of us to compact cancer. In 2018 alone, over 17 million people worldwide received a cancer diagnosis. Surgery, chemotherapy, and radiation are the best-known methods for treating cancer. But chemotherapy and other treatments have changed the outlook for so many. There has been advancement in I PET/CT scan, and what we see in this PET/CT scan is the CT scan will show you where the bones are, and the PET scan will show you where tumors are. 

Chimeric antigen receptor therapy, or CAR therapy,-,  groundbreaking cancer treatment, where  T cells are collected from a patient’s blood that supercharges part of a patient's own immune system to attack and kill tumors. It can cost up to 150,000 dollars to make the CAR T cells for each patient. More research is warranted to make this more efficient and increase affordability to all patients. The development of nanobiotechnology-based early cancer detection that scans for traces of disease in the form of special biomarkers is in progress. finding nanotechnology-derived cancer detection will greatly enhance your odds of survival.

Using a patient’s own immune system to fight his or her cancer, known as immunotherapy producing remarkable results, eliminating cancer completely in some patients with highly advanced melanoma. The promise of precision medicine offers customized care, with treatments that match our genetics and personal histories to people with all kinds of cancer, both common and rare cancer thus minimizing side effects than more traditional ones developed for the average patient. Epigenetic therapy is in the infancy stage where targeting epigenetic enzymes, that regulate a cell’s genetic programming. Rather than destroy cancer cells, the therapies seek to set the cells on a path back toward normal growth and development.

We now see the start of a scientific revolution – genome medicine. We know more about the patients that enter clinics with cancer now than ever before. And we're able, finally, to answer the question that's been so pressing for so many years. We know that there are perhaps 40,000 unique mutations affecting more than 10,000 genes and that there are 500 of these genes that are bonafide drivers, causes of cancer.  It's been known for decades what causes this malignancy. It's three proteins: ras, myc, p53. . This is old information we've known since about the 80s, yet we struggle to bring powerful and targeted therapies to cancer patients. 

Despite these advances, the vast majority of cancer patients continue to receive highly toxic chemotherapy. Doctors are addicted to offering chemotherapy treatment to patients is due to a simple fact: It works or maybe they have the only option to treat cancer. However, most cancers are sensitive to chemotherapy, and many exhibits severe toxicity. Although cancer patients get the short-term solution and may live longer, they often must endure the long-term toxicities that are induced by chemotherapy.  We envision a future where chemotherapy is only used as a last resort, and where each patient with metastatic cancer is managed by a precision treatment of highly effective and minimally toxic therapies to eliminate their cancer. their cancer. We are optimistic that within the next decade, this type of technology will be available, helping protect cancer patients and future generations, and will provide a strong beacon of hope.